Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56751 - 56775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	SUSD3	203328	upregulated	panobinostat results in increased expression of SUSD3 mRNA	9q22.31	A21037
Panobinostat	Approved Investigational	SV2C	22987	upregulated	panobinostat results in increased expression of SV2C mRNA	5q13.3	A21037
Panobinostat	Approved Investigational	SYK	6850	upregulated	panobinostat results in increased expression of SYK mRNA	9q22.2	A21037
Panobinostat	Approved Investigational	SYNE1	23345	upregulated	panobinostat results in increased expression of SYNE1 mRNA	6q25.2	A21037
Panobinostat	Approved Investigational	SYNE3	161176	upregulated	panobinostat results in increased expression of SYNE3 mRNA	14q32.13	A21037
Panobinostat	Approved Investigational	SYNGR1	9145	upregulated	panobinostat results in increased expression of SYNGR1 mRNA	22q13.1	A21037
Panobinostat	Approved Investigational	SYNPR	132204	upregulated	panobinostat results in increased expression of SYNPR mRNA	3p14.2	A21037
Panobinostat	Approved Investigational	SYT11	23208	downregulated	panobinostat results in decreased expression of SYT11 mRNA	1q22	A21037
Panobinostat	Approved Investigational	SYT4	6860	upregulated	panobinostat results in increased expression of SYT4 mRNA	18q12.3	A21037
Panobinostat	Approved Investigational	SYT7	9066	upregulated	panobinostat results in increased expression of SYT7 mRNA	11q12.2	A21037
Panobinostat	Approved Investigational	TAC1	6863	upregulated	panobinostat results in increased expression of TAC1 mRNA	7q21.3	A21037
Panobinostat	Approved Investigational	TACC1	6867	upregulated	panobinostat results in increased expression of TACC1 mRNA	8p11.22	A21037
Panobinostat	Approved Investigational	TACSTD2	4070	upregulated	panobinostat results in increased expression of TACSTD2 mRNA	1p32.1	A21037
Panobinostat	Approved Investigational	TAGLN2	8407	upregulated	panobinostat results in increased expression of TAGLN2 mRNA	1q23.2	A21037
Panobinostat	Approved Investigational	TANC1	85461	upregulated	panobinostat results in increased expression of TANC1 mRNA	2q24.2	A21037
Panobinostat	Approved Investigational	TARS	6897	upregulated	panobinostat results in increased expression of TARS mRNA	5p13.3	A21037
Panobinostat	Approved Investigational	TBC1D30	23329	downregulated	panobinostat results in decreased expression of TBC1D30 mRNA	12q14.3	A21037
Panobinostat	Approved Investigational	TBC1D8	11138	downregulated	panobinostat results in decreased expression of TBC1D8 mRNA	2q11.2	A21037
Panobinostat	Approved Investigational	TDGF1	6997	upregulated	panobinostat results in increased expression of TDGF1 mRNA	3p21.31	A21037
Panobinostat	Approved Investigational	TDRKH	11022	downregulated	panobinostat results in decreased expression of TDRKH mRNA	1q21.3	A21037
Panobinostat	Approved Investigational	TDRP	157695	upregulated	panobinostat results in increased expression of TDRP mRNA	8p23.3	A21037
Panobinostat	Approved Investigational	TENM2	57451	upregulated	panobinostat results in increased expression of TENM2 mRNA	5q34	A21037
Panobinostat	Approved Investigational	TES	26136	upregulated	panobinostat results in increased expression of TES mRNA	7q31.2	A21037
Panobinostat	Approved Investigational	TFAP2A	7020	upregulated	panobinostat results in increased expression of TFAP2A mRNA	6p24.3	A21037
Panobinostat	Approved Investigational	TFAP2B	7021	upregulated	panobinostat results in increased expression of TFAP2B mRNA	6p12.3	A21037

Displaying entries 56751 - 56775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability